HKB's Non-Human Primate (NHP) Models represent the gold standard for translational preclinical research in autoimmune disease drug development. Our NHP models offer superior predictive value due to their genetic, anatomical, and physiological similarities to humans. With over 50 validated NHP disease models and GLP/AAALAC/ISO9001 certifications, we provide pharmaceutical companies and biotech firms with reliable primate models for target validation, efficacy screening, and mechanism studies. Each model is carefully characterized with detailed baseline data, enabling precise assessment of therapeutic interventions. Our experienced team supports study design, model selection consultation, and regulatory-compliant data collection to accelerate your autoimmune drug development pipeline from discovery to clinical entry.